Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Immune Therapeutics Inc (OTCQB:IMUN)

0.20
Delayed Data
As of Jul 31
 +0.065 / +48.15%
Today’s Change
0.05
Today|||52-Week Range
0.37
+17.65%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Biotechnology
MARKET CAP
$28.9M

Company Description

Immune Therapeutics, Inc. is a biopharmaceutical company focused on developing and commercializing therapeutics to treat cancer, HIV or AIDS and autoimmune diseases by combating these chronic and often life-threatening diseases through the activation and rebalancing of the body's immune system. The company was founded by Noreen Griffin on December 2, 1993 and is headquartered in Orlando, FL.

Contact Information

Immune Therapeutics, Inc.
37 North Orange Avenue
Orlando Florida 32801
P:(888) 613-8802
Investor Relations:

Employees

Shareholders

Individual stakeholders7.09%
Mutual fund holders--
Other institutional--

Top Executives

Noreen GriffinChief Executive Officer & Director
Peter J. AronstamChief Financial Officer
Fengping ShanDirector & Chief Scientific Officer
Angus George DalgleishCMO, Director-Research & Development
Annie FosterVice President-Clinical & Regulatory Affairs